Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Assessment of the Department of Veterans Affairs Airborne ...
Released: February 28, 2017
Concerns over possible adverse effects of wartime exposure to smoke from trash burning in Iraq, Afghanistan, and other locations in Southwest Asia have stimulated both research and Congressional action. Public Law 112-260, § 201 (enacted January 10, 2013) directed the Department of Veterans Affairs (VA) to establish and maintain a registry for service members who may have been exposed to toxic airborne chemicals and fumes generated by open burn pits. VA asked the National Academies to take on the responsibility to fulfill a provision of this law that called for an independent scientific organization to prepare a report addressing issues related to the establishment and conduct of the registry and use of the information it collects.
Countering Violent Extremism Through Public Health Practice ...
Released: February 17, 2017
Countering violent extremism (CVE) consists of various prevention and intervention approaches to increase the resilience of communities and individuals to radicalization toward violent extremism, to provide nonviolent avenues for expressing grievances, and to educate communities about the threat of recruitment and radicalization to violence.
Real-World Evidence Generation and Evaluation of ...
Released: February 15, 2017
The traditional process for evaluating new therapeutics does not produce the evidence that patients, clinicians, and payers need for real-world decisions. The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data are numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to assessing how therapeutics affect patients’ lives through measurement of lifestyle changes.
Integration of FDA and NIOSH Processes Used to Evaluate ...
Released: February 01, 2017
The Food and Drug Administration (FDA) and the National Institute for Occupational Safety and Health (NIOSH) have responsibilities for evaluating and regulating respiratory protective devices (RPDs) for health care workers. To provide input to NIOSH and FDA and to discuss potential next steps to integrate the two agencies’ processes to certify and approve N95 respirators for use in health care settings, a workshop was held by the National Academies of Sciences, Engineering, and Medicine (the National Academies).
International Perspectives on Integrating Ethical, Legal, and ...
Released: January 09, 2017
Emerging neurotechnologies—devices and techniques designed to collect information about the brain or affect its function—are becoming increasingly important due to scientific and technological advances and a persistent need to develop effective therapies to address the large global burden of neurological and psychiatric disease. The Organisation for Economic Co-operation and Development (OECD)—in collaboration with Arizona State University and the National Academies of Sciences, Engineering, and Medicine—held a workshop in Washington, DC, on Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science.
Review of NASA's Evidence Reports on Human Health Risks ...
Released: January 06, 2017
The National Academies of Science, Engineering and Medicine at the request of the National Aeronautics & Space Administration (NASA) and with guidance from the National Academies’ Standing Committee on Aerospace Medicine and the Medicine of Extreme Environments, has established a committee to review NASA’s Evidence Reports on Human Health Risks. These evidence reports focus on human health risks for long-duration and exploration spaceflights. To review the eight NASA evidence reports that were examined in 2016, the National Academies assembled a 13-member committee with multidisciplinary expertise.
Exploring Strategies to Improve Cardiac Arrest Survival ...
Released: December 20, 2016
Cardiac arrest often strikes seemingly healthy individuals without warning and without regard to age, gender, race, or health status. Following the release of the 2015 Institute of Medicine (IOM) consensus report, Strategies to Improve Cardiac Arrest Survival: A Time to Act, eight sponsors asked the Health and Medicine Division to hold a workshop to assemble diverse stakeholders who would explore the barriers and opportunities for advancing the IOM recommendations.
Enhancing BioWatch Capabilities Through Technology and ...
Released: December 05, 2016
In response to the 2015 Government Accountability Office (GAO) report Biosurveillance: DHS Should Not Pursue BioWatch Upgrades or Enhancements Until System Capabilities Are Established, the Department of Homeland Security (DHS) requested that the National Academies of Sciences, Engineering, and Medicine conduct a workshop to further explore the findings of the 2015 GAO report and discuss the impact these findings may have with regard to the future development of the technical capabilities of the BioWatch program.
Strengthening the workforce to Support Community Living and ...
Released: November 22, 2016
As the demographics of the United States shift toward a population that is made up of an increasing percentage of older adults and people with disabilities, the workforce that supports and enables these individuals is also shifting to meet the demands of this population. To better understand how the nation’s workforce can be strengthened to meet these demands, the Health and Medicine Division and the Division of Behavioral and Social Sciences and Education of the National Academies of Sciences, Engineering, and Medicine, convened a public workshop with support from multiple sponsors.
Developing Multimodal Therapies for Brain Disorders ...
Released: November 18, 2016
Califf was the keynote speaker at a workshop on multimodality therapies for brain disorders, convened by the National Academies of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous Systems Disorders. The workshop brought together key stakeholders to examine the general principles underlying multimodal therapies and to explore challenges, potential barriers, and opportunities for their development from multiple perspectives, including scientific, clinical, regulatory, and financial. These proceedings chronicle the presentations and discussions at the workshop.